Tolmar
Focus: Tolmar is a Colorado-based biotech specializing in small-molecule oncology therapies, with a diversified portfolio spanning hormone therapies, anticonvulsants, and dermatology products. The company operates with a mature commercial presence centered on peak-lifecycle products like JATENZO and ELIGARD.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Tolmar
AI assessmentNot HiringNo open roles listed right now. Follow Tolmar to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$5M Part DStable
Peak12.7yr
Sole revenue driver (100% concentration); 15-year exclusivity runway provides structural stability but concentrates company risk.
Help build intelligence for Tolmar
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.